Dissolution and absorption modeling: Model expansion to simulate the effects of precipitation, water absorption, longitudinally changing intestinal permeability, and controlled release on drug absorption

被引:46
作者
Johnson, KC [1 ]
机构
[1] Intellipharm LLC, Niantic, CT 06357 USA
关键词
absorption; ADME; controlled release; dissolution; modeling; particle size; permeability; precipitation; water absorption;
D O I
10.1081/DDC-120024179
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A previously described model for simulating drug dissolution, absorption, and pharmacokinetics has been expanded beyond the original application of simulating immediate-release dosage forms to include simulation of drug precipitation, water absorption from the gastrointestinal tract, changing gastrointestinal permeability. disintegration, and controlled-release and dissolution front a GITS-type dosage form. A mathematical description of the model is presented as well as a retrospective analysis of nifedipine to demonstrate the utility of the model. The fourth-order Runge-Kutta numerical method was used to solve the series Of Coupled differential equations used to Simulate the process of dissolution, absorption, and drug disposition. The model was able to Simulate the clinically demonstrated effect for drug particle size on nifedipine plasma concentrations for an immediate-release dosage form. Further simulations indicated that drug particle size was less important for a GITS-type dosage form Lit a release rate of 1.7 mg/hr compared to rate of 17 mg/hr. Hypothetical calculations simulated the potential effect of drug precipitation, water absorption, and changing permeability on drug plasma concentrations. The expanded model increases the utility of a previously described model in providing guidance in drug development and selection.
引用
收藏
页码:833 / 842
页数:10
相关论文
共 14 条
[1]   PHYSICOCHEMICAL ASPECTS OF DRUG RELEASE .15. INVESTIGATION OF DIFFUSIONAL TRANSPORT IN DISSOLUTION OF SUSPENDED, SPARINGLY SOLUBLE DRUGS [J].
BISRAT, M ;
ANDERBERG, EK ;
BARNETT, MI ;
NYSTROM, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 80 (2-3) :191-201
[2]  
Chung M, 1987, Am J Med, V83, P10, DOI 10.1016/0002-9343(87)90630-9
[4]   MIXING-TANK MODEL FOR PREDICTING DISSOLUTION RATE CONTROL OF ORAL ABSORPTION [J].
DRESSMAN, JB ;
FLEISHER, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (02) :109-116
[5]   NIFEDIPINE KINETICS AND BIOAVAILABILITY AFTER SINGLE INTRAVENOUS AND ORAL DOSES IN NORMAL SUBJECTS [J].
FOSTER, TS ;
HAMANN, SR ;
RICHARDS, VR ;
BRYANT, PJ ;
GRAVES, DA ;
MCALLISTER, RG .
JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 23 (04) :161-170
[6]  
FRIEND DR, 2001, DRUG DELIVERY TECH, V1, P36
[7]  
HEGASY A, 1993, Patent No. 5264446
[8]  
HINTZ RJ, 1989, INT J PHARM, V51, P519
[9]   PHARMACOKINETICS OF ORAL NIFEDIPINE - RELEVANCE OF THE DISTRIBUTION PHASE [J].
HOYOVADILLO, C ;
CASTANEDAHERNANDEZ, G ;
HERRERA, JE ;
VIDALGARATE, J ;
SALAZAR, LA ;
MORENORAMOS, A ;
CHAVEZ, F ;
TENA, I ;
HONG, E .
JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 29 (03) :251-256
[10]   DISSOLUTION MODELING - FACTORS AFFECTING THE DISSOLUTION RATES OF POLYDISPERSE POWDERS [J].
LU, ATK ;
FRISELLA, ME ;
JOHNSON, KC .
PHARMACEUTICAL RESEARCH, 1993, 10 (09) :1308-1314